Motion artefacts pose significant problems for the acquisition and analysis of MRI data. In movement disorders, severe motion-related artefacts can result in data being discarded as non-usable. It is not known to what degree clinical movement symptoms can predict in-scanner motion artefacts, and thus, whether researchers can target recruitment for MRI studies based on clinical presentation. Here we investigate whether movement severity in Huntington’s disease, a neurodegenerative movement disorder, can predict in-scanner motion artefacts in arterial spin labelling data. We find that motion magnitude and variability is not more pronounced in Huntington’s disease and not related to symptom severity.